Free Trial

X4 Pharmaceuticals (XFOR) Insider Trading & Ownership

X4 Pharmaceuticals logo
$4.32 -0.18 (-4.00%)
As of 11:10 AM Eastern
This is a fair market value price provided by Massive. Learn more.

X4 Pharmaceuticals (NASDAQ:XFOR) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
1.13%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$252.56K
Number Of
Insiders Selling
(Last 12 Months)
0
Get XFOR Insider Trade Alerts

Want to know when executives and insiders are buying or selling X4 Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

XFOR Insider Buying and Selling by Quarter

X4 Pharmaceuticals Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/23/2025
Adam R Craig
Adam R Craig
Chairman
Buy86,206$2.90$249,997.40  
5/16/2025Buy1,032$2.48$2,559.36  
(Data available from 1/1/2013 forward)

XFOR Insider Trading Activity - Frequently Asked Questions

The list of insiders at X4 Pharmaceuticals includes Adam R Craig, Adam S Mostafa, Arthur Taveras, Israel Niv, Mark Baldry, Mary Dibiase, Michael S Wyzga, Murray Stewart, Paula Ragan, and Tuvia Barlev. Learn more on insiders at XFOR.

1.13% of X4 Pharmaceuticals stock is owned by insiders. Learn more on XFOR's insider holdings.

The following insiders have purchased XFOR shares in the last 24 months: Adam R Craig ($249,997.40), and Mark Baldry ($2,559.36).

Insiders have purchased a total of 87,238 XFOR shares in the last 24 months for a total of $252,556.76 bought.

The following insiders have sold XFOR shares in the last 24 months: Adam S. Mostafa ($160,494.00), Mark Baldry ($19,546.50), Mary Dibiase ($48,581.10), and Paula Ragan ($183,956.40).

Insiders have sold a total of 26,111 X4 Pharmaceuticals shares in the last 24 months for a total of $412,578.00 sold.



This page (NASDAQ:XFOR) was last updated on 5/12/2026 by MarketBeat.com Staff.
From Our Partners